Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Simonelli

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Lung Cancer (Amsterdam, Netherlands)|January 3, 2013
Reproducibility of the WHO classification of thymomas: practical implicationsP A Zucali, L Di Tommaso, I Petrini, et al.
British Journal of Cancer|June 12, 2014
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyG L Ceresoli, F Grosso, P A Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2011
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter surveyP A Zucali, M Simonelli, G Michetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canalP A Ott, S A Piha-Paul, P Munster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinomaM Simonelli, P Zucali, A Santoro, et al.
ESMO Open|March 16, 2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastomaM Caccese, I Desideri, V Villani, et al.
ESMO Open|August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyM Simonelli, E Garralda, F Eskens, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Lung Cancer (Amsterdam, Netherlands)|January 3, 2013
Reproducibility of the WHO classification of thymomas: practical implicationsP A Zucali, L Di Tommaso, I Petrini, et al.
British Journal of Cancer|June 12, 2014
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyG L Ceresoli, F Grosso, P A Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2011
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter surveyP A Zucali, M Simonelli, G Michetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canalP A Ott, S A Piha-Paul, P Munster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinomaM Simonelli, P Zucali, A Santoro, et al.
ESMO Open|March 16, 2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastomaM Caccese, I Desideri, V Villani, et al.
ESMO Open|August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyM Simonelli, E Garralda, F Eskens, et al.
Pageof 4